Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the effects of multiple-dose clarithromycin on the single-dose
pharmacokinetics (PK) of apixaban with parameters like Cmax, AUC(INF), and AUC(0-T).